Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Insomnia is an factor aggravaging the course of cardiovascular diseases: modern understanding of the problem and ways of solution ; Инсомния - фактор, отягчающий течение сердечно-сосудистых заболеваний: современное понимание проблемы и пути решения

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      This work was supported by the Kazan Federal University Strategic Academic Leadership Program (PRIORITY-2030).; Работа выполнена за счет средств Программы стратегического академического лидерства Казанского (Приволжского) федерального университета (Приоритет-2030).
    • Publication Information:
      REMEDIUM GROUP Ltd.
    • Publication Date:
      2024
    • Collection:
      Medical Council (E-Journal) / Медицинский Совет
    • Abstract:
      Insomnia is a common and serious health problem associated with a significant and growing health burden. About 10% of the adult population suffers from chronic insomnia, and 20% suffer from it periodically. Insomnia is associated with an increased risk of mental (depression, cognitive impairment), somatic (arterial hypertension, coronary heart disease, arrhythmias, metabolic disorders) and occupational problems. The review examines current data on the effect of insomnia on the course of diseases of the cardiovascular system, showing the negative impact of insomnia on coronary heart disease, arterial hypertension and cardiac arrhythmias. A high prevalence (40-80%) of sleep apnea is observed in patients with cardiovascular disease, including coronary artery disease, atrial fibrillation, heart failure and hypertension, leading to adverse cardiac outcomes. A negative fact is the steady (epidemic) increase in cardiovascular diseases among young people aged 18 to 50 years, due to lifestyle changes and an increase in the level of stress factors. Individuals with insomnia have a significantly increased risk of myocardial infarction, cardiovascular mortality, cardiovascular disease morbidity, and all-cause mortality compared with healthy individuals. The optimal drug for the treatment of insomnia may be doxylamine, especially its most easily titrated form - a solution in drops. The drug has a high level of safety and is highly effective in the treatment of insomnia. A concomitant positive effect of the drug may be a decrease in the intensity of vestibular symptoms. ; Инсомния является распространенной и серьезной проблемой здравоохранения, ассоциированной со значительным и растущим бременем для здоровья. Около 10% взрослого населения страдает от хронической инсомнии, а 20% страдает от нее периодически. Инсомния ассоциирована с повышенным риском психических (депрессия, когнитивные нарушения), соматических (артериальная гипертония, ишемическая болезнь сердца, аритмии, нарушение метаболизма) и профессиональных проблем. В ...
    • File Description:
      application/pdf
    • Relation:
      https://www.med-sovet.pro/jour/article/view/8497/7469; Gauld C, Lopez R, Geoffroy PA, Morin CM, Guichard K, Giroux E et al. A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration. Sleep Med Rev. 2021;58:101439. https://doi.org/10.1016/j.smrv.2021.101439.; Jansen PR, Watanabe K, Stringer S, Skene N, Bryois J, Hammerschlag AR, de Leeuw CA et al. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat Genet. 2019;51(3):394-403. https://doi.org/10.1038/s41588-018-0333-3.; Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e56-e67. https://doi.org/10.1161/CIR.0000000000000988.; Rissling MB, Gray KE, Ulmer CS, Martin JL, Zaslavsky O, Gray SL et al. Sleep Disturbance, Diabetes, and Cardiovascular Disease in Postmenopausal Veteran Women. Gerontologist. 2016;56(Suppl. 1):S54-66. https://doi.org/10.1093/geront/gnv668.; Thorpy MJ. Classification of sleep disorders. Neurotherapeutics. 20129;4:687-701. https://doi.org/10.1007/s13311-012-0145-6.; Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387-1394. https://doi.org/10.1378/chest.14-0970.; Kaur H, Spurling BC, Bollu PC. Chronic Insomnia. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK526136.; Bhaskar S, Hemavathy D, Prasad S. Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities. J Family Med Prim Care. 2016;5(4):780-784. https://doi.org/10.4103/2249-4863.201153.; Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med. 2004;66(5):645-650. https://doi.org/10.1097/01.psy.0000138126.90551.62.; Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213-218. https://doi.org/10.1093/sleep/30.2.213.; Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3(5 Suppl.):S7-S10. Available at: https://pubmed.ncbi.nlm.nih.gov/17824495.; Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97-1 1 1 . https://doi.org/10.1053/smrv.2002.0186.; Bonnet M. Etiology of insomnia. Sleep Medicine. 2006;7(7):544. https://doi.org/10.1016/j.sleep.2006.05.012.; Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract. 2002;51(3):229-235. Available at: https://pubmed.ncbi.nlm.nih.gov/11978233.; Ali E, Shaikh A, Yasmin F, Sughra F, Sheikh A, Owais R et al. Incidence of adverse cardiovascular events in patients with insomnia: A systematic review and meta-analysis of real-world data. PLoS ONE. 2023;18(9):e0291859. https://doi.org/10.1371/journal.pone.0291859.; Lechat B, Appleton S, Melaku YA, Hansen K, McEvoy RD, Adams R et al. Comorbid insomnia and sleep apnoea is associated with all-cause mortality. Eur Respir J. 2022;60(1):2101958. https://doi.org/10.1183/13993003.01958-2021.; Siebmanns S, Johansson L, Sandberg J, Johansson P, Brostrom A. Experiences and Management of Incidents That Influence Sleep in Patients With Cardiovascular Disease and Insomnia. J Cardiovasc Nurs. 2020;35(4):364-374 . https://doi.org/10.1097/JCN.0000000000000626.; Pengo MF, Javaheri S, Sanchez-de-la-Torre M, Schwarz EI. What cardiologists should know about sleep. Eur Heart J. 2022;43(31):2911-2913. https://doi.org/10.1093/eurheartj/ehac349.; Chirinos JA, Gurubhagavatula I, Teff K, Rader DJ, Wadden TA, Townsend R et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370(24):2265-2275. https://doi.org/10.1056/NEJMoa1306187.; Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018;15(4):230-240. https://doi.org/10.1038/nrcardio.2017.154.; Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health. 2003;45(6):344-350. https://doi.org/10.1539/joh.45.344.; Coryell VT, Ziegelstein RC, Hirt K, Quain A, Marine JE, Smith MT. Clinical correlates of insomnia in patients with acute coronary syndrome. Int Heart J. 2013;54(5):258-265. https://doi.org/10.1536/ihj.54.; Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I. Insomnia and the risk of incident heart failure: a population study. Eur Heart J. 2014;35(21):1382-1393. https://doi.org/10.1093/eurheartj/eht019.; Bertisch SM, Pollock BD, Mittleman MA, Buysse DJ, Bazzano LA, Gottlieb DJ, Redline S. Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study. Sleep. 2018;41(6):zsy047. https://doi.org/10.1093/sleep/zsy047.; Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601-608. https://doi.org/10.1093/sleep/34.5.601.; Huang BH, Duncan MJ, Cistulli PA, Nassar N, Hamer M, Stamatakis E. Sleep and physical activity in relation to all-cause, cardiovascular disease and cancer mortality risk. Br J Sports Med. 2022;56(13):718-724. https://doi.org/10.1136/bjsports-2021-104046.; Yan B, Yang J, Zhao B, Fan Y, Wang W, Ma X. Objective Sleep Efficiency Predicts Cardiovascular Disease in a Community Population: The Sleep Heart Health Study. J Am Heart Assoc. 2021;10(7):e016201. https://doi.org/10.1161/jaha.120.016201.; Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014;21(1):57-64. https://doi.org/10.1177/2047487312460020.; He Q, Zhang P, Li G, Dai H, Shi J. The association between insomnia symptoms and risk of cardiocerebral vascular events: A meta-analysis of prospective cohort studies. Eur J Prev Cardiol. 2017;24(10):1071-1082. https://doi.org/10.1177/2047487317702043.; Hu S, Lan T, Wang Y, Ren L. Individual Insomnia Symptom and Increased Hazard Risk of Cardiocerebral Vascular Diseases: A Meta-Analysis. Front Psychiatry. 2021;12:654719. https://doi.org/10.3389/fpsyt.2021.654719.; Kanno Y, Yoshihisa A, Watanabe S, Takiguchi M, Yokokawa T, Sato A et al. Prognostic Significance of Insomnia in Heart Failure. Circ J. 2016;80(7):1571-1577. https://doi.org/10.1253/circj.CJ-16-0205.; Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. Melatonin and cardiovascular disease: myth or reality? Rev Esp Cardiol (Engl Ed). 2012;65(3):215-218. https://doi.org/10.1016/j.recesp.2011.10.009.; Krell SB, Kapur VK. Insomnia complaints in patients evaluated for obstructive sleep apnea. Sleep Breath. 2o05;9(3):1o4-11O. https://doi.org/10.1007/s11325-005-0026-x.; Chung KF. Insomnia subtypes and their relationships to daytime sleepiness in patients with obstructive sleep apnea. Respiration. 2005;72(5):460-465. https://doi.org/10.1159/000087668.; Grandner MA, Alfonso-Miller P, Fernandez-Mendoza J, Shetty S, Shenoy S, Combs D. Sleep: important considerations for the prevention of cardiovascular disease. Curr Opin Cardiol. 2016;31(5):551-565. https://doi.org/10.1097/HCO.0000000000000324.; Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care. 2009;32(11):1980-1985. https://doi.org/10.2337/dc09-0284.; Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol. 2015;66:143-172. https://doi.org/10.1146/annurev-psych-010213-115205.; King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS. Short sleep duration and incident coronary artery calcification. JAMA. 2008;300(24):2859-2866. https://doi.org/10.1001/jama.2008.867.; Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43(4):678-683. https://doi.org/10.1016/j.jacc.2003.07.050.; Maniaci A, Di Luca M, Lechien JR, Iannella G, Grillo C, Grillo CM et al. Lateral pharyngoplasty vs. traditional uvulopalatopharyngoplasty for patients with OSA: systematic review and meta-analysis. Sleep Breath. 2022;26(4):1539-1550. https://doi.org/10.1007/s11325-021-02520-y.; Bhatt P, Patel V, Motwani J, Choubey U, Mahmood R, Gupta V, Jain R. Insomnia and Cardiovascular Health: Exploring the Link Between Sleep Disorders and Cardiac Arrhythmias. Curr Cardiol Rep. 2023;25(10):1211-1221. https://doi.org/10.1007/s11886-023-01939-x.; Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-847. https://doi.org/10.1161/CIRCULATIONAHA.113.005119.; Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746-2751. https://doi.org/10.1093/eurheartj/eht280.; Chen LY, Chung MK, Allen LA, Ezekowitz M, Furie KL, McCabe P et al. American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council. Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association. Circulation. 2018;137(20):e623-e644. https://doi.org/10.1161/CIR.0000000000000568.; Hald EM, Løchen ML, Mathiesen EB, Wilsgaard T, Njølstad I, Brækkan SK, Hansen JB. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: The Tromsø study. Res Pract Thromb Haemost. 2020;4(6):1004–1012. https://doi.org/10.1002/rth2.12351.; Sum-Ping O, Geng Y-J. Impact of sleep on cardiovascular health: a narrative review. Heart and Mind. 2022;6(3):120-126. https://doi.org/10.4103/hm.hm_29_22.; Zhang L, Li G, Bao Y, Liu M. Role of sleep disorders in patients with cardiovascular disease: A systematic review. Int J Cardiol Cardiovasc Risk Prev. 2024;21:200257. https://doi.org/10.1016/j.ijcrp.2024.200257.; Полуэктов МГ, Пчелина ПВ. Хроническая инсомния: современная модель «трех П» и основанные на ней методы лечения. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(12):141-147. https://doi.org/10.17116/jnevro2015115112141-147.; Shaha DP. Insomnia Management: A Review and Update. J Fam Pract. 2023;72(6 Suppl.):S31-S36. https://doi.org/10.12788/jfp.0620.; Курушина ОВ, Барулин АЕ, Багирова ДЯ. Современные подходы к лечению инсомнии в общетерапевтической практике. Медицинский совет. 2019;(6):20-26. https://doi.org/10.21518/2079-701X-2019-6-20-26.; Koren G, Clark S, Hankins GD, Caritis SN, Umans JG, Miodovnik M et al. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy. BMC Pregnancy Childbirth. 2016;16(1):371. https://doi.org/10.1186/s12884-016-1172-9; Бурчаков ДИ, Тардов МВ. Инсомния в практике терапевта: роль доксиламина. Медицинский совет. 2020;(2):45-53. https://doi.org/10.21518/2079-701X-2020-2-45-53.; Мельников АЮ, Лаврик СЮ, Бикбулатова ЛФ, Рагинене ИГ, Иванова ЯА, Захаров АВ. Эффективность препарата реслип (доксиламин) при острой инсомнии: многоцентровое открытое сравнительное рандомизированное исследование. Журнал неврологии и психиатрии им. С.С. Корсакова. 2017;117(4-2):56-59. https://doi.org/10.17116/jnevro20171174256-59.; Стрыгин КН. Роль центральных блокаторов гистаминовых рецепторов в лечении инсомнии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(4-2):73-82. https://doi.org/10.17116/jnevro20181184273.; Романов ДВ, Юзбашян ПГ. Острая инсомния: опыт применения доксиламина. Медицинский еовет. 2020;(21):267-273. https://doi.org/10.21518/2079-701X-2020-21-267-273.; Brott NR, Reddivari AKR. Doxylamine. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK551646.; Gomez Perez S, Hassel I, Giesel B, Schweimer MT, Iwanowitsch A. Retrospective post-authorisation safety study investigating the relationship of first-generation antihistamines with sedative effect and the risk of falls in older patients. Pharmazie. 2020;75(12):666-670. https://doi.org/10.1691/ph.2020.0784.; Gomez Perez S, Hassel I, Torben Schweimer M, Gilbert S, Iwanowitsch A. Post-authorisation safety study on doxylamine and fall risk - a patient survey in German pharmacies. SelfCare. 2024;14(1):9-20. Available at: https://selfcarejournal.com/article/post-authorisation-safety-study-on-doxylamine-and-fall-risk-a-patient-survey-in-german-pharmacies.; https://www.med-sovet.pro/jour/article/view/8497
    • Accession Number:
      10.21518/ms2024-292
    • Online Access:
      https://www.med-sovet.pro/jour/article/view/8497
      https://doi.org/10.21518/ms2024-292
    • Rights:
      Authors publishing their articles in this journal shall agree to the following:Authors reserve the copyright to the work and grant the journal a license to publish the work for the first time Creative Commons Attribution License (CC BY- NC-ND), which allows other persons to distribute this work with the obligatory preservation of references to the authors of the original work and the original publication in this journal.Authors reserve the right to conclude separate contractual arrangements regarding the non-exclusive distribution of the work version in the form published here (for example, posting it in the institute’s repository, publication in a book), with reference to its original publication in this journal.Authors have the right to post work on the Internet (for example, in the institute’s repository or personal website) before and during the process of considering it by this journal, as this can result in a productive discussion and more references to this work. ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License (CC BY- NC-ND), которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию.Авторы имеют право размещать работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу. (См. The Effect of Open Access).
    • Accession Number:
      edsbas.3CA91A76